Pioglitazone Unknown Status Phase 4 Trials for ESRD Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01253928Pioglitazone, Body Composition,Insulin Sensitivity and Protein Metabolism in ESRD